Since CD144 is a constituent marker of ECs, highly increased levels of CD144+EEVs in circulation indicate impairment of vascular endothelium and their contribution to PAH development in SLE-PAH patients. This evidence concerns the gene CDH5 and systemic lupus erythematosus.